Alkem Laboratories Limited — Others, 07-02-2025: Copy of Newspaper Publication

Alkem Laboratories has announced a board meeting to discuss the interim dividend, with February 14, 2025, set as the record date for eligible shareholders. The financials reflect a total income from operations of ₹5,362.86 crore for the quarter ended December 31, 2024, and a net loss after tax of ₹26.30 crore.

Despite this loss, the approval of an interim dividend suggests a positive outlook for shareholder returns. The approach demonstrates confidence in the company's operational stability, though investors should monitor ongoing profitability trends and earnings recovery. The company’s total reserves remain solid at ₹13,440.42 crore.